Acompanhe as Notícias da Recifes

The Ervebo vaccine has proved safe and effective against the more common Zaire strain of the Ebola virus, and World Health Organization experts say early data, notably from animal trials, suggest it may also offer some protection against the rarer Bundibugyo strain, which is spre

Optimization models do an excellent job of ensuring products get where they are needed in the most efficient way possible, but those models require an impractical amount of computing power when dealing with large-scale problems—such as distributing vaccines to millions of people.

An international team of researchers has developed an innovative strategy for producing new vaccines. They created a genetically modified version of the chikungunya virus that replicates only once yet still trains the immune system to defend itself without causing disease. In tes

The encouraging results of the world's first trial of a fridge-free tetanus-diphtheria vaccine could improve access worldwide to crucial treatments while reducing carbon emissions. Fridge-free vaccines have the potential to transform vaccine delivery by reducing dependence on ref

The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhea in young Territorians. The study, led by Adelaide University in partnership with NT Health, found that two d

Trump determined to link life-saving shots to autism, despite science and political risk. O recorte ajuda a contextualizar a pauta dentro de Tech.

Scientists have kept vaccines stable at room temperature for a year, which could transform global vaccination. O recorte ajuda a contextualizar a pauta dentro de Comportamento.

The mFlusiva vaccine for older people is first made with mRNA platform key to ending coronavirus pandemicThe Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid-19 pand

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up. Mais do que repetir a manchete, o ponto aqui e entender o que essa mudanca revela e por que ela merece atencao.